Search Results

There are 14679 results for: content related to: Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer

  1. Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Article first published online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  2. You have free access to this content
    Diethylstilbestrol in castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E727–E735, Anna Wilkins, Mehdi Shahidi, Chris Parker, Ranga Gunapala, Karen Thomas, Robert Huddart, Alan Horwich and David Dearnaley

    Article first published online : 30 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11546.x

  3. New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Article first published online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  4. Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Article first published online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  5. You have free access to this content
    Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E82–E89, Alessandro Tenuta, Laurence Klotz and Jayson L. Parker

    Article first published online : 2 DEC 2013, DOI: 10.1111/bju.12309

  6. Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1729–1735, Mari Nakabayashi, Lilian Werner, Kevin D. Courtney, Geoffrey Buckle, William K. Oh, Glen J. Bubley, Julia H. Hayes, Douglas Weckstein, Aymen Elfiky, Danny M. Sims, Philip W. Kantoff and Mary-Ellen Taplin

    Article first published online : 29 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11456.x

  7. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 8, October 2012, Pages: 1149–1155, Toshiki Kijima, Yasuhisa Fujii, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Fumitaka Koga, Hitoshi Masuda, Satoru Kawakami and Kazunori Kihara

    Article first published online : 28 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10959.x

  8. Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

    BJU International

    Volume 111, Issue 1, January 2013, Pages: 44–52, Hielke J. Meulenbeld, Jean P. Bleuse, Elio M. Vinci, Eric Raymond, Giordano Vitali, Armando Santoro, Luigi Dogliotti, Rossana Berardi, Federico Cappuzzo, Scott T. Tagawa, Cora N. Sternberg, Maria G. Jannuzzo, Mariangela Mariani, Anna Petroccione and Ronald de Wit

    Article first published online : 29 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11404.x

  9. Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Article first published online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x

  10. Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1580–1588, Che-Kai Tsao, Matthew D. Galsky, Alexander C. Small, Tiffany Yee and William K. Oh

    Article first published online : 18 SEP 2012, DOI: 10.1111/j.1464-410X.2012.11445.x

  11. You have free access to this content
    Abstracts

    BJU International

    Volume 111, Issue S1, April 2013, Pages: 13–119,

    Article first published online : 27 MAR 2013, DOI: 10.1111/bju.12069

  12. Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC)

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 367–375, Cristina Suárez, Rafael Morales-Barrera, Victor Ramos, Isaac Núñez, Claudia Valverde, Jacques Planas, Juan Morote, Xavier Maldonado and Joan Carles

    Article first published online : 12 APR 2013, DOI: 10.1111/bju.12110

  13. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue

    BJU International

    Volume 113, Issue 5, May 2014, Pages: 822–829, Fernando Korkes, Marilia Germanos de Castro, Stenio de Cassio Zequi, Lívia Nardi, Auro Del Giglio and Antonio Carlos de Lima Pompeo

    Article first published online : 31 OCT 2013, DOI: 10.1111/bju.12339

  14. Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?

    BJU International

    Nicolas Mottet, Noel Clarke, Maria De Santis, Filiberto Zattoni, Juan Morote and Steven Joniau

    Article first published online : 15 JUL 2014, DOI: 10.1111/bju.12736

  15. Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 111, Issue 8, June 2013, Pages: 1269–1280, William L. Dahut, Ravi A. Madan, Joyson J. Karakunnel, David Adelberg, James L. Gulley, Ismail B. Turkbey, Cindy H. Chau, Shawn D. Spencer, Marcia Mulquin, John Wright, Howard L. Parnes, Seth M. Steinberg, Peter L. Choyke and William D. Figg

    Article first published online : 18 FEB 2013, DOI: 10.1111/j.1464-410X.2012.11667.x

  16. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Article first published online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  17. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers

    BJU International

    Volume 110, Issue 6, September 2012, Pages: 840–845, Neesha C. Dhani, Urban Emmenegger, Laurie Adams, Jan Jongstra, Ian F. Tannock, Srikala S. Sridhar, Jennifer J. Knox, John R. Day, Jack Groskopf and Anthony M. Joshua

    Article first published online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10922.x

  18. You have free access to this content
    Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database

    BJU International

    Volume 110, Issue 4, August 2012, Pages: 492–498, Christopher J. Keto, William J. Aronson, Martha K. Terris, Joseph C. Presti, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Article first published online : 17 NOV 2011, DOI: 10.1111/j.1464-410X.2011.10754.x

  19. Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer

    BJU International

    Volume 114, Issue 2, August 2014, Pages: 168–176, Daniel P. Nguyen, Jinyi Li, Shalini S. Yadav and Ashutosh K. Tewari

    Article first published online : 20 FEB 2014, DOI: 10.1111/bju.12488

  20. Role of targeted therapy in the treatment of advanced prostate cancer

    BJU International

    Volume 105, Issue 6, March 2010, Pages: 748–767, Karim Fizazi, Cora N. Sternberg, John M. Fitzpatrick, R. William Watson and Majid Tabesh

    Article first published online : 25 FEB 2010, DOI: 10.1111/j.1464-410X.2010.09236.x